73 results
424B5
RNLX
Renalytix Plc
15 May 24
Prospectus supplement for primary offering
10:09am
information technology systems;
the potential direct or indirect impact of the COVID-19 pandemic and the Russia-Ukraine or Hamas-Israel armed conflict … information technology systems;
the potential direct or indirect impact of the COVID-19 pandemic and the conflict in Ukraine on the global economy and our
8-K
EX-99.1
RNLX
Renalytix Plc
15 May 24
Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024
7:00am
business of the COVID-19 pandemic or similar public health crises. These and other risks are described more fully in the Company’s filings
424B3
wjb8vqf6e27aw
7 May 24
Prospectus supplement
6:29pm
8-K
wnj07npcpfgs2g8bhy
26 Apr 24
Allotment and issue of the Second Tranche Placing Shares
7:43am
8-K
rhb5r7xi20rzktv3bjad
9 Apr 24
Entry into a Material Definitive Agreement
4:51pm
424B5
e2gswt6452cpwuezr
9 Apr 24
Prospectus supplement for primary offering
4:31pm
8-K
EX-99.1
g8iunw9 cgzzv
8 Apr 24
Regulation FD Disclosure
7:44am
8-K
EX-10.1
vfbj8w5
29 Mar 24
Entry into a Material Definitive Agreement
4:00pm
8-K
EX-99.1
ek3dvcrx5yc1h5f
14 Mar 24
Guidelines highlight the importance of risk prediction and personalized treatment to reduce risk
7:15am
8-K
EX-99.2
ahjcaj0hdc5
13 Mar 24
Entry into a Material Definitive Agreement
7:00am
8-K
EX-99.1
atihmscma2p0vis67hx2
13 Mar 24
Entry into a Material Definitive Agreement
7:00am
8-K
s9op1glk eg74c
13 Mar 24
Entry into a Material Definitive Agreement
7:00am
8-K
vbqq9p6m71w68ov 8qj
29 Feb 24
Regulation FD Disclosure
6:05am
8-K
EX-99.1
zmkdt
15 Feb 24
Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2024
7:00am
8-K
EX-99.1
ali3k 3np6im
9 Feb 24
Regulation FD Disclosure
7:00am